Trial NCT01722292

View at ClinicalTrials.gov 
Org. Study IDs: 14631
Secondary IDs: 2012-003174-83 I4J-MC-HHBE

Last trial update was posted on 2018-12-28

MeSH Interventions

Carboplatin Etoposide

MeSH Conditions

Small Cell Lung Carcinoma

Other Conditions


Stopping Reasons

Change in clinical strategy.

Limitations And Caveats

Due to strategic reasons, the Phase 2 portion was not initiated, and further clinical development was stopped.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID